Cargando…

Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy

[Image: see text]

Detalles Bibliográficos
Autores principales:	Ring, Hans Christian, Egeberg, Alexander, Zachariae, Claus, Thomsen, Simon F., Gyldenløve, Mette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805069/ https://www.ncbi.nlm.nih.gov/pubmed/35791762 http://dx.doi.org/10.1111/bjd.21744

Ejemplares similares

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
por: Gyldenløve, Mette, et al.
Publicado: (2023)

The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
por: Ring, Hans Christian, et al.
Publicado: (2022)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Special considerations for women with hidradenitis suppurativa
por: Collier, Erin, et al.
Publicado: (2020)

Atypical Hidradenitis Suppurativa on the Leg in a Psoriatic Patient
por: Yasuda, Masahito, et al.
Publicado: (2020)

Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa
por: Yao, Yiqiu, et al.
Publicado: (2023)

Management of mild hidradenitis suppurativa: our greatest challenge yet
por: van der Zee, H.H., et al.
Publicado: (2021)

Cryosurgery-Induced Pneumomediastinum in a Young Woman with Hidradenitis Suppurativa
por: Gomes, Nuno Miguel Preto, et al.
Publicado: (2022)

Decreased glomerular function is associated with disease severity in patients with hidradenitis suppurativa
por: Nielsen, Valdemar W., et al.
Publicado: (2022)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

High and discordant prevalences of clinical and sonographic enthesitis in patients with hidradenitis suppurativa
por: van Straalen, K.R., et al.
Publicado: (2020)

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
por: BOTVID, Sofia H. C., et al.
Publicado: (2023)

Guidelines for the management of hidradenitis suppurativa: recommendations supported by the Centre of Evidence of the French Society of Dermatology
por: Bertolotti, A., et al.
Publicado: (2021)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

The Relevant Oral Burden of Patients with Hidradenitis Suppurativa
por: Damiani, Giovanni, et al.
Publicado: (2023)

Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativa
por: Nielsen, Valdemar Wendelboe, et al.
Publicado: (2021)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Hidradenitis suppurativa: Basic considerations for its approach: A narrative review
por: Anduquia-Garay, Felipe, et al.
Publicado: (2021)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches
por: Ardon, C.B., et al.
Publicado: (2020)

Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020)

Clinical considerations in the management of hidradenitis suppurativa in women [Image: see text]
por: Kozera, Emily K., et al.
Publicado: (2021)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Secondary prevention of hidradenitis suppurativa
por: Kurzen, Hjalmar, et al.
Publicado: (2019)

Facklamia hominis in hidradenitis suppurativa
por: Basal, Yasmeen, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Surgical Treatment in Hidradenitis Suppurativa
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Dietary Factors and Hidradenitis Suppurativa
por: Shen, Alan S., et al.
Publicado: (2023)

Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool
por: Guart, Jiddu A, et al.
Publicado: (2021)

Novel nicastrin mutation in hidradenitis suppurativa–Dowling–Degos disease clinical phenotype: more than just clinical overlap?
por: Garcovich, S., et al.
Publicado: (2020)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nju9e9f93c14li0mpf9etlj665